• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Sagent Recalls Phenylephrine Hydrochloride Injection americanpharmaceuticalreview
    March 19, 2021
    Sagent Pharmaceuticals announced the voluntary nationwide recall of three lots of Phenylephrine Hydrochloride Injection, USP (10 mg/mL). This product was manufactured by Indoco Remedies Ltd. and distributed by Sagent Pharmaceuticals, Inc. Sagent has ...
  • lonza Shimadzu FDA Approves Drug to Treat Dangerously Low Blood Pressure americanpharmaceuticalreview
    December 27, 2017
    The U.S. Food and Drug Administration (FDA) approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service